GOVX · GeoVax Labs, Inc.
$0.77
+0.03 (+4.76%)
At close · Jul 27
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors collectively raise substantial doubt about the Company's ability to continue as a going concern. Management believes that we will be successful in securing the additional capital required to continue the Company's planned operations, but that our plans do not fully alleviate the substantial doubt about the Company's ability to operate as a going concern.”View the 10-Q filed May 14, 2026
Market Cap
$2.54M
Shares
3.47M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Kelly McKee | Chief Medical Officer | $361,034 |
| Mark Newman | President and Chief Executive Officer | $291,500 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| David A. Dodd | CEO | $652,012 |
| Mark Newman | President and Chief Executive Officer | $437,366 |
| Mark Reynolds | CFO | $421,400 |
| Kelly McKee | Chief Medical Officer | $362,580 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| David A. Dodd | CEO | $677,110 |
| Mark Reynolds | CFO | $478,326 |
| Mark Newman | President and Chief Executive Officer | $248,759 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| David A. Dodd | CEO | $726,743 |
| Mark Reynolds | CFO | $500,751 |
| Farshad Guirakhoo | Chief Scientific Officer | $163,321 |
| Mark Newman | President and Chief Executive Officer | $99,617 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Farshad Guirakhoo | Chief Scientific Officer | $271,648 |
| David A. Dodd | CEO | $250,914 |
| Mark Reynolds | CFO | $240,017 |
| Mark Newman | President and Chief Executive Officer | — |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Farshad Guirakhoo | Chief Scientific Officer | $282,675 |
| Mark Reynolds | CFO | $253,406 |
| David A. Dodd | CEO | $157,283 |